Because increased levels of CRP predict the subsequent risk for de novo depression, these findings suggest that the documented immune findings are not merely epiphenomena of depression, but actually contribute to the genesis of the disorder [15]. The gene discussed is CRP; the disease is depressive symptom measurement.